Literature DB >> 22465021

Novel endocrine aspects of prostate cancer.

Tapio Visakorpi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22465021     DOI： 10.1016/j.mce.2012.03.015

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN： 0303-7207            Impact factor:   4.102


× No keyword cloud information.
  1 in total

1.  CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.

Authors:  Anchit Khanna; Jayant K Rane; Kati K Kivinummi; Alfonso Urbanucci; Merja A Helenius; Teemu T Tolonen; Outi R Saramäki; Leena Latonen; Visa Manni; John E Pimanda; Norman J Maitland; Jukka Westermarck; Tapio Visakorpi
Journal:  Oncotarget       Date:  2015-08-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.